CIK 0001818794 · Large accelerated filer
Dyne Therapeutics, Inc.
Sign in to watch- Ticker
- DYN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364883909
- Phone
- (781) 786-8230
- Business address
- 1560 TRAPELO ROAD, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $40,000
- in 1 filing
- Open-market sales, last 90 days
- $247,777
- in 3 filings, $248K under 10b5-1 plans
Net −$207,777. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-07 | Rhodes Jason P Director | Sale 10b5-1 | −124,379 | $23.17 | $2.9M | 4,099,069 |
| 2026-07-07 | Rhodes Jason P Director | Sale 10b5-1 | −29,587 | $23.62 | $699K | 4,069,482 |
| 2026-07-07 | Rhodes Jason P Director | Sale 10b5-1 | −62,543 | $23.17 | $1.4M | 1,154,994 |
| 2026-07-07 | Rhodes Jason P Director | Sale 10b5-1 | −14,844 | $23.62 | $351K | 1,140,150 |
| 2026-07-07 | Rhodes Jason P Director | Sale 10b5-1 | −49,193 | $23.17 | $1.1M | 826,719 |
| 2026-07-07 | Rhodes Jason P Director | Sale 10b5-1 | −11,665 | $23.62 | $276K | 815,054 |
| 2026-07-07 | Rhodes Jason P Director | Sale 10b5-1 | −5,000 | $23.61 | $118K | 2,962 |
| 2026-07-06 | Rhodes Jason P Director | Sale 10b5-1 | −253,039 | $22.79 | $5.8M | 4,223,448 |
| 2026-07-06 | Rhodes Jason P Director | Sale 10b5-1 | −127,182 | $22.79 | $2.9M | 1,217,537 |
| 2026-07-06 | Rhodes Jason P Director | Sale 10b5-1 | −100,019 | $22.79 | $2.3M | 875,912 |
| 2026-06-29 | Rhodes Jason P Director | Sale 10b5-1 | −102,969 | $21.14 | $2.2M | 4,476,487 |
| 2026-06-29 | Rhodes Jason P Director | Sale 10b5-1 | −51,756 | $21.14 | $1.1M | 1,344,719 |
| 2026-06-29 | Rhodes Jason P Director | Sale 10b5-1 | −40,702 | $21.14 | $860K | 975,931 |
| 2026-06-26 | Rhodes Jason P Director | Sale 10b5-1 | −162,954 | $21.28 | $3.5M | 4,579,456 |
| 2026-06-26 | Rhodes Jason P Director | Sale 10b5-1 | −81,903 | $21.28 | $1.7M | 1,396,475 |
| 2026-06-26 | Rhodes Jason P Director | Sale 10b5-1 | −64,411 | $21.28 | $1.4M | 1,016,633 |
| 2026-06-25 | Rhodes Jason P Director | Sale 10b5-1 | −12,699 | $21.10 | $268K | 4,742,410 |
| 2026-06-25 | Rhodes Jason P Director | Sale 10b5-1 | −6,382 | $21.10 | $135K | 1,478,378 |
| 2026-06-25 | Rhodes Jason P Director | Sale 10b5-1 | −5,019 | $21.10 | $106K | 1,081,044 |
| 2026-06-25 | Lucera Erick Chief Financial Officer | Sale | −2,362 | $20.37 | $48K | 121,563 |
Page 2 of 29 · 561 trades